{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:50:12Z","timestamp":1791654612326,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.josat.2026.210115","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:20:31Z","timestamp":1789428031000},"page":"210115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A systematic review of psychosocial interventions to increase adherence to medications for opioid use disorder"],"prefix":"10.1016","volume":"191","author":[{"given":"Kevin","family":"Wenzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Clinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sragvi","family":"Pattanaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Fishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2026.210115_bb0005","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004147.pub4","article-title":"Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence","author":"Amato","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2S","key":"10.1016\/j.josat.2026.210115_bb0010","first-page":"1","article-title":"The ASAM national practice guideline for the treatment of opioid use disorder: 2020 focused update","volume":"14","author":"American Society of Addiction Medicine","year":"2020","journal-title":"Journal of Addiction Medicine"},{"issue":"11","key":"10.1016\/j.josat.2026.210115_bb0030","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1111\/add.15514","article-title":"The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: A 15-year retrospective cohort study","volume":"116","author":"Bharat","year":"2021","journal-title":"Addiction"},{"issue":"10","key":"10.1016\/j.josat.2026.210115_bb0050","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/jamapsychiatry.2021.1969","article-title":"Contingency management for patients receiving medication for opioid use disorder","volume":"78","author":"Bol\u00edvar","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"10.1016\/j.josat.2026.210115_bb0055","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/archpsyc.58.8.755","article-title":"Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: Efficacy of contingency management and significant other involvement","volume":"58","author":"Carroll","year":"2001","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1016\/j.josat.2026.210115_bb0070","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1037\/1064-1297.10.1.54","article-title":"Contingency management to enhance naltrexone treatment of opioid dependence: A randomized clinical trial of reinforcement magnitude","volume":"10","author":"Carroll","year":"2002","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/j.josat.2026.210115_bb9000","series-title":"Final Data","article-title":"State unintentional drug overdose reporting system (SUDORS)","author":"Centers for Disease Control and Prevention","year":"2026"},{"key":"10.1016\/j.josat.2026.210115_bb0075","series-title":"Retention strategies for medications for addiction treatment in adults with opioid use disorder: A rapid evidence review","author":"Chan","year":"2020"},{"issue":"16","key":"10.1016\/j.josat.2026.210115_bb0080","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1001\/jama.2023.1207","article-title":"Trends in buprenorphine initiation and retention in the United States, 2016\u20132022","volume":"329","author":"Chua","year":"2023","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.josat.2026.210115_bb0085","doi-asserted-by":"crossref","DOI":"10.1111\/add.16364","article-title":"Patient navigation for pregnant individuals with opioid use disorder: Results of a randomized multi-site pilot trial","volume":"119","author":"Cochran","year":"2023","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.josat.2026.210115_bb0090","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2023.5138","article-title":"Telehealth mindfulness-oriented recovery enhancement vs usual care in individuals with opioid use disorder and pain: A randomized clinical trial","volume":"81","author":"Cooperman","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.josat.2026.210115_bb0095","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugalcdep.2011.06.023","article-title":"Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: A randomized controlled trial","volume":"120","author":"DeFulio","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2026.210115_bb0100","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.ypmed.2012.04.017","article-title":"The use of incentives to reinforce medication adherence","volume":"55","author":"DeFulio","year":"2012","journal-title":"Preventive Medicine"},{"issue":"1","key":"10.1016\/j.josat.2026.210115_bb0110","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1037\/a0030743","article-title":"Employment-based reinforcement of adherence to oral naltrexone treatment in unemployed injection drug users","volume":"21","author":"Dunn","year":"2013","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/j.josat.2026.210115_bb0120","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsat.2019.10.003","article-title":"Adjunctive memantine for opioid use disorder treatment: A systematic review","volume":"107","author":"Elias","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2026.210115_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2025.112789","article-title":"Extended-release naltrexone versus oral naltrexone for substance use disorders: A systematic review and meta-analysis","volume":"274","author":"Elmosalamy","year":"2025","journal-title":"Drug and Alcohol Dependence"},{"issue":"7","key":"10.1016\/j.josat.2026.210115_bb0130","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1360-0443.2011.03400.x","article-title":"Employment-based reinforcement of adherence to depot naltrexone in unemployed opioid-dependent adults: A randomized controlled trial","volume":"106","author":"Everly","year":"2011","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.josat.2026.210115_bb0135","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1037\/0022-006X.71.3.432","article-title":"Behavioral family counseling and naltrexone for male opioid-dependent patients","volume":"71","author":"Fals-Stewart","year":"2003","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1016\/j.josat.2026.210115_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108076","article-title":"A randomized comparison of extended-release naltrexone with or without patient navigation vs enhanced treatment-as-usual for incarcerated adults with opioid use disorder","volume":"117","author":"Farabee","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.josat.2026.210115_bb0145","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJMoa055255","article-title":"Counseling plus buprenorphine\u2013naloxone maintenance therapy for opioid dependence","volume":"355","author":"Fiellin","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.josat.2026.210115_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2024.209352","article-title":"Engagement, initiation, and retention in medication treatment for opioid use disorder among young adults: A narrative review of challenges and opportunities","volume":"166","author":"Fishman","year":"2024","journal-title":"Journal of Substance Use and Addiction Treatment"},{"issue":"5","key":"10.1016\/j.josat.2026.210115_bb0155","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/ajad.13176","article-title":"Examination of correlates of OUD outcomes in young adults: Secondary analysis from the XBOT Trial","volume":"30","author":"Fishman","year":"2021","journal-title":"The American Journal on Addictions"},{"issue":"3","key":"10.1016\/j.josat.2026.210115_bb0160","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/add.15181","article-title":"A pilot randomized controlled trial of assertive treatment including family involvement and home delivery of medication for young adults with opioid use disorder","volume":"116","author":"Fishman","year":"2021","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2026.210115_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109123","article-title":"Effectiveness of peer recovery support services on stages of the opioid use disorder treatment cascade: A systematic review","volume":"229","author":"Gormley","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"issue":"343","key":"10.1016\/j.josat.2026.210115_bb0180","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.josat.2026.210115_bb0185","doi-asserted-by":"crossref","first-page":"209602","DOI":"10.1016\/j.josat.2024.209602","article-title":"An initial randomized controlled trial of a Combined Medication and Behavioral Activation Treatment (CoMBAT) for people with opioid use disorder","volume":"169","author":"Hughto","year":"2024","journal-title":"Journal of Substance Use and Addiction Treatment"},{"issue":"7","key":"10.1016\/j.josat.2026.210115_bb0195","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/add.14180","article-title":"Extended-release injectable naltrexone for opioid use disorder: a systematic review","volume":"113","author":"Jarvis","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2026.210115_bb0200","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5376","article-title":"Dedicated outreach service for hard to reach patients with tuberculosis in London: Observational study and economic evaluation","volume":"343","author":"Jit","year":"2011","journal-title":"BMJ"},{"issue":"108367","key":"10.1016\/j.josat.2026.210115_bb0205","article-title":"The role of social network support in treatment outcomes for medication for opioid use disorder: A systematic review","volume":"127","author":"Kumar","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.josat.2026.210115_bb0210","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/pubmed\/fdaf009","article-title":"Effectiveness of text message reminder and motivational interview on adherence to methadone treatment in Vietnam: A randomized controlled trial","volume":"47","author":"Le","year":"2025","journal-title":"Journal of Public Health (Oxford, England)"},{"issue":"10","key":"10.1016\/j.josat.2026.210115_bb0225","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1111\/add.12266","article-title":"Comparison of behavioral treatment conditions in buprenorphine maintenance","volume":"108","author":"Ling","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2026.210115_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2018.00113","article-title":"Educational and behavioral counseling in a methadone maintenance treatment program in China: A randomized controlled trial","volume":"9","author":"Liu","year":"2018","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/j.josat.2026.210115_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102311","article-title":"Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: A pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial","volume":"66","author":"Marsden","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.josat.2026.210115_bb0240","doi-asserted-by":"crossref","first-page":"111099","DOI":"10.1016\/j.drugalcdep.2024.111099","article-title":"Mobile medication adherence platform for buprenorphine (MAP4BUP): A phase I feasibility, usability and efficacy pilot randomized clinical trial","volume":"256","author":"McPherson","year":"2024","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2026.210115_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001333.pub2","article-title":"Oral naltrexone maintenance treatment for opioid dependence","volume":"1","author":"Minozzi","year":"2006","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.josat.2026.210115_bb0255","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jsat.2018.11.011","article-title":"A randomized clinical trial of the Recovery Line among methadone treatment patients with ongoing illicit drug use","volume":"97","author":"Moore","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"71","key":"10.1016\/j.josat.2026.210115_bb0275","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"British Medical Journal"},{"key":"10.1016\/j.josat.2026.210115_bb0280","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.drugpo.2018.03.012","article-title":"The effect of Housing First on adherence to methadone maintenance treatment","volume":"56","author":"Parpouchi","year":"2018","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2026.210115_bb0285","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2147\/PPA.S277861","article-title":"Monitoring and improving naltrexone adherence in patients with substance use disorder","volume":"15","author":"Perez-Macia","year":"2021","journal-title":"Patient Preference and Adherence"},{"issue":"2","key":"10.1016\/j.josat.2026.210115_bb0295","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0376-8716(98)00152-5","article-title":"Improvement in naltrexone treatment compliance with contingency management","volume":"54","author":"Preston","year":"1999","journal-title":"Drug and Alcohol Dependence"},{"issue":"12","key":"10.1016\/j.josat.2026.210115_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244401","article-title":"Evaluating comparative effectiveness of psychosocial interventions adjunctive to opioid agonist therapy for opioid use disorder: A systematic review with network meta-analyses","volume":"15","author":"Rice","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.josat.2026.210115_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2025.209858","article-title":"Real-world longitudinal treatment trajectories following opioid use disorder diagnosis among commercially insured beneficiaries in the United States","volume":"182","author":"Rizk","year":"2026","journal-title":"Journal of Substance Use and Addiction Treatment"},{"issue":"5","key":"10.1016\/j.josat.2026.210115_bb0315","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.addbeh.2012.01.013","article-title":"The effect of telephonic patient support on treatment for opioid dependence: Outcomes at one year follow-up","volume":"37","author":"Ruetsch","year":"2012","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.josat.2026.210115_bb0320","article-title":"Follow-up patterns at a low-threshold mobile medical unit providing opioid use disorder care in an urban setting: A group-based trajectory modeling approach, 14 April 2026, preprint (version 1) available at","author":"Shah","year":"2026","journal-title":"Research Square"},{"issue":"4","key":"10.1016\/j.josat.2026.210115_bb0330","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jsat.2012.07.011","article-title":"Brief versus extended counseling along with buprenorphine\/naloxone for HIV-infected opioid dependent patients","volume":"43","author":"Tetrault","year":"2012","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2026.210115_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108917","article-title":"Video directly observed therapy for patients receiving office-based buprenorphine \u2013 A pilot randomized controlled trial","volume":"227","author":"Tsui","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"issue":"11","key":"10.1016\/j.josat.2026.210115_bb0350","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1111\/j.1360-0443.2004.00884.x","article-title":"Adherence to pharmacotherapy in patients with alcohol and opioid dependence","volume":"99","author":"Weiss","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2026.210115_bb0360","doi-asserted-by":"crossref","first-page":"209366","DOI":"10.1016\/j.josat.2024.209366","article-title":"A pilot randomized controlled trial of medication adherence therapy: Psychosocial leverage using a significant other (MAT-PLUS) for individuals on extended-release naltrexone","volume":"163","author":"Wenzel","year":"2024","journal-title":"Journal of Substance Use and Addiction Treatment"},{"key":"10.1016\/j.josat.2026.210115_bb0355","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000001713","article-title":"Development and testing of a peer recovery support services intervention for retention on medications for opioid use disorder","author":"Wenzel","year":"2026","journal-title":"Journal of Addiction Medicine"},{"issue":"4","key":"10.1016\/j.josat.2026.210115_bb0370","article-title":"The use of long-acting injectable antipsychotics (LAI) in the serious mental illness (SMI) patients enrolled in an assertive community treatment (ACT) program","volume":"13","author":"Yee","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.josat.2026.210115_bb0375","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2024-015633","article-title":"The performance of digital technologies for measuring tuberculosis medication adherence: A systematic review","volume":"9","author":"Zary","year":"2024","journal-title":"BMJ Global Health"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926002353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926002353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:32:15Z","timestamp":1791653535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875926002353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":51,"alternative-id":["S2949875926002353"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2026.210115","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of psychosocial interventions to increase adherence to medications for opioid use disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2026.210115","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"210115"}}